Skip to main content
Clinical Trials/DRKS00022872
DRKS00022872
Completed
Not Applicable

Investigations on biomarker search in patients with bronchial carcinoma under antibody (checkpoint blockade) therapy

Krankenhaus Martha-Maria Halle-Dölau0 sites30 target enrollmentNovember 2, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
C34.9
Sponsor
Krankenhaus Martha-Maria Halle-Dölau
Enrollment
30
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
November 2, 2020
End Date
July 6, 2023
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Krankenhaus Martha-Maria Halle-Dölau

Eligibility Criteria

Inclusion Criteria

  • Patients must be able to give consent themselves
  • \- signed consent form
  • \- histologically confirmed SCLC with indication for palliative immunochemotherapy

Exclusion Criteria

  • \- histologically confirmed NSCLC
  • \- previous immunotherapies

Outcomes

Primary Outcomes

Not specified

Similar Trials